Business Standard
Tuesday, Nov 24, 2009
 
drived banner
drived banner
  Advanced Search
Feedback | RSS
Content Guide
Follow us on  
  Home  ||||||||| 
 BS Headlines | News Now | BS Weekend | The strategist | The Smart Investor | Lunch with BS | Columnists | BS 1000
Home Live Markets | Smart Portfolios II
  Search:
     Search Results    us market
 
SEC bars Mohit Khanna from association with broker, dealer13-NOV-09
The US market regulator Securities and Exchange Commission (SEc) has barred an Indian-origin person Mohit Khanna, who was allegedly running a Ponzi scheme and defrauded investors, from associating with any broker or dealer in the market.
US markets end positive despite disappointing job data07-NOV-09
US stocks added 3% for the week after ending Friday's session slightly higher, shrugging off government data showing the unemployment rate hit 10.2% - the highest in 26-1/2 years.
US markets end off day's high05-NOV-09
US Federal Reserve's decision to keep rates near zero dragged the markets off the day's high.
US markets slip as worries resurface31-OCT-09
US markets slipped a day after the highest rally in three months. Financial dragged the most as recovery worries surfaced once again.
More than 18,000 H-1B visas yet to be grabbed01-OCT-09
Reflecting the dire straits of the US job market and strict regulations imposed by the Congress, over 18,000 of the H-1B visas, once the most sought after by Indian professionals, is yet to be grabbed.
Dr Reddy's recalls four products from US market30-SEP-09
Hyderabad-based drug firm Dr Reddy's Laboratories (DRL) today said it is recalling four of its drugs used in the treatment of ailments such as allergy, depression and high cholesterol from the US market.
US markets edge up on M&A deals29-SEP-09
US markes edged up on Monday on news of merger activities among big corporates.
US markets slip after three days18-SEP-09
US markets slipped marginally on Thursday even as positive stimulus came in the form of strong housing data numbers.
M&M to enter US market in first quarter of 201004-SEP-09
Auto maker Mahindra & Mahindra (M&M) has said today it will begin US operations in the first quarter of 2010 with two new variants of SUV Scorpio, besides two vehicles in the Indian market over the next six months.
M&M to enter US market in 1st quarter of 201003-SEP-09
Auto maker Mahindra & Mahindra today said it will begin US operations in the first quarter of 2010 with two new variants of SUV Scorpio besides two vehicles in the Indian market over the next six months.
US market regulator focuses on role of auditors in Satyam fraud31-AUG-09
The US capital market regulator Securities and Exchange Commission (SEC) has completed its probe into the multi-crore rupee Satyam fraud case in India, especially the role of auditors. A team of the Commission came to India following filing of over a dozen class action lawsuits in the US against the promoters and managers of the IT firm on behalf of investors, who purchased American Depository Shares of the company between January 6, 2004 (the listing date in the US) and January 6, 2009 (the day before Raju’s letter).
Slow US recovery to hit IT firms30-AUG-09
The delay in recovery of US economy, according to analysts and companies, will eat into the top- and bottom-lines of most Indian IT firms, even as they see a surge in demand from some European countries, including the UK and France, along with emerging geographies like Australia and West Asia. The reason is simple — most of the Indian IT services firms derive over 60 per cent of their revenues from the North Americas, including the US.
Sun Pharma invalidates Eli Lilly's Gemzar patent19-AUG-09
Sun Pharmaceuticals has succeeded in invalidating a key patent of Eli Lilly's block buster cancer medicine Gemzar (gemcitabine injection) in the US market.
US markets slip ahead of vital data11-AUG-09
US markets slipped on Monday ahead of vital economic data, including Federal Reserve's statement on interest rates, due this week.
Sun Pharma uses own plants for US market after after Caraco trouble02-AUG-09
In spite of a major regulatory clampdown on its US subsidiary, Caraco, Mumbai-based Sun Pharmaceuticals is trying hard to keep its US market share intact. The company is relying on its own manufacturing facilities to deliver goods to the US market. All eight ANDAs (abbreviated new drug applications) for sales permission in the US filed during the first quarter of the current financial year (Q1FY2010) came from Sun’s facilities.
Go to page:   1    2    3    4    5    6    Next  [  ]    
  
Most Popular
Read
E-Mailed
Commented
   
- Infosys BPO chief quits; to join HDFC Standard Life
- Mittal plans 6 mt plant in Karnataka
- Search for Tejas engine nears its end
- Kurbaan could be Karan Johar's first flop
- Tea with BS: Amitabh Bachchan
 
 More  
BS Poll
Cast Your Vote
 
   
 
Should educational institutions be allowed to approach the capital market?
  Yes  No
Submit

  Hot Searches  
 
Amitabh Bachchan | N Chandrasekaran | Swine Flu | Mukesh Ambani | Anil Ambani | TCS | Infosys |  Air India |  Duronto |  Pranab Mukherjee | Sonia Gandhi | Congress | Rahul Gandhi |  Bigg Boss |  New Pension Scheme |  Service tax |  Excise duty |  Sebi | Tech Mahindra |  Ramalinga Raju |  Satyam |  Reliance  |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  |  B-School | DLF  Sensex |  Tax calculator | Home Loan  | Bollywood | Personal Finance |  inflation | oil prices |  World Bank | Reliance Infratel |  HDFC |  Barack Obama  
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Site Map | Contact Us | Feedback